Amicus Therapeutics FOLD
$ 9.78
-1.86%
Quarterly report 2024-Q3
added 11-06-2024
Amicus Therapeutics General and Administrative Expenses 2011-2024 | FOLD
Annual General and Administrative Expenses Amicus Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
275 M | 213 M | 193 M | 156 M | 170 M | 127 M | 88.7 M | 71.2 M | 47.3 M | 20.7 M | 18.9 M | 19.4 M | 19.9 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
275 M | 18.9 M | 109 M |
Quarterly General and Administrative Expenses Amicus Therapeutics
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
75.1 M | 73.6 M | - | 65.7 M | 65.4 M | 74 M | - | 47.3 M | 53.4 M | 58.1 M | - | 46.1 M | 42.3 M | 46.7 M | - | 37.8 M | 34.7 M | 40.2 M | - | 39.7 M | 42.6 M | 44.3 M | - | 31.9 M | 29.2 M | 27.4 M | - | 21.6 M | 19.3 M | 19.1 M | - | 17.5 M | 19.3 M | 15.7 M | - | 15.4 M | 8.28 M | 6.43 M | - | 5.27 M | 4.75 M | 5.18 M | - | 4.64 M | 4.83 M | 4.82 M | - | 5 M | 5.82 M | 4.1 M | - | 4.84 M | 6.72 M | 4.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
75.1 M | 4.1 M | 28.7 M |